TMCnet News

Company Profile for Izun Pharmaceuticals Corporation
[February 27, 2015]

Company Profile for Izun Pharmaceuticals Corporation


Izun Pharmaceuticals is a US based pharmaceutical company with a wholly owned R&D center in Israel. Izun's technology platform allows it to develop botanical drugs by optimizing and purifying the extracted botanical compounds to yield polymolecular drug candidates. These patented products are designed to impact on multiple specific receptor targets. The main therapeutic focus is on agents that can reduce inflammation and accelerate healing. Izun is currently active in developing therapeutic products for a number of indications including: oral care, oncology support, wound care, women's health care, gastrointestinal disease and dermatologic conditions. Izun uses the inherent advantage of the natural botanical sources to deliver robust clinical results with an excellent safety profile. Izun has currently received approval for a number of oral care products that are marketed. Additional clinical studies are in progress for indications, including diabetic foot ulcers and atrophic vaginitis.





 

Company:

  Izun Pharmaceuticals Corporation
 

Headquarters Address:

One Rockefeller Plaza
11th floor
New York, NY 10003
 

Main Telephone:

2126186357
 

Website:

www.izunpharma.com

 

Type of Organization:

Private
 

Industry:

Health
 

Key Executives:

CEO: William Levine

Director: Elliot Hahn

CFO: Les Kraus

 

Customer Service

Contact:

Mordechai Levinson

Phone (News - Alert):

972-72-245-8950

Email:

[email protected]



[ Back To TMCnet.com's Homepage ]